Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.

Expert review of proteomics - 1 Apr 2020

Basisty Nathan, Kale Abhijit, Patel Sandip, Campisi Judith, Schilling Birgit

Abstract excerpt

INTRODUCTION: Cellular senescence is a rapidly growing field with potential relevance for the treatment of multiple human diseases. In the last decade, cellular senescence and the senescence-associated secretory phenotype (SASP) have emerged as central drivers of aging and many chronic diseases, including cancer, neurodegeneration, heart disease and osteoarthritis. Major efforts are underway to develop drugs that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cellular Senescence
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exosomes

Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Share to Phenotype

Share to Proteome

Share to Proteomics

Share to Telomeres, Telomerase, and Senescence

Source

Open in PubMed Open full text

Identifiers

PMID: 32425074
DOI: 10.1080/14789450.2020.1766976
PMCID: PMC7416420

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.PMID 32425074Read ↗

Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic TechnologiesSemantic proximity Read ↗

A Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker DevelopmentSemantic proximity Read ↗

Cellular senescence: a key therapeutic target in aging and diseasesSemantic proximity Read ↗

Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.Semantic proximity Read ↗

A proteomic atlas of senescence-associated secretomes for aging biomarker development.Semantic proximity Read ↗

Biomarkers of Cellular Senescence and Aging: Current State‐of‐the‐Art, Challenges and Future PerspectivesSemantic proximity Read ↗

Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.Semantic proximity Read ↗

Senescent cells at the crossroads of aging, disease, and tissue homeostasisSemantic proximity Read ↗

Targeting cellular senescence with senotherapeutics: senolytics and senomorphicsSemantic proximity Read ↗

NIH SenNet Consortium: Mapping Senescent Cells in the Human Body to Understand Health and DiseaseSemantic proximity Read ↗

Biomarkers to identify and isolate senescent cells.Semantic proximity Read ↗

Cellular Senescence: The Sought or the Unwanted?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.